2023International Journal of Applied PharmaceuticsOpen access

MOLECULAR DYNAMICS SIMULATIONS OF THE STK630921 INTERACTIONS TO INTERLEUKIN-17A

Fransiscus Deddy Riandono, Enade Perdana Istyastono

Open full text 3 citations

Abstract

Objective: This research aimed to investigate the stability of the STK630921-Interleukin 17A (IL-17A) complex and to predict important residues that interact during molecular dynamics simulations. Methods: Molecular docking simulations were performed, followed by molecular dynamics (MD) simulations and the free energy of binding calculations using YASARA-Structure. The identification of interacting residues was done using PyPLIF HIPPOS. Molecular docking simulations were performed on the IL-17A binding pocket with the compound 4-[({N-[(4-Oxo-3,4-dihydro-1-phthalazinyl) acetyl] alanyl} amino) methyl] cyclohexane carboxylic acid or known as STK630921. The best-docked pose was selected for the 50 ns MD simulations production run. The MD simulations snapshots were then analyzed to see the stability of IL-17A and for the identification of interacting residues, followed by Molecular Mechanics/Poisson–Boltzmann and surface area (MM/PBSA) analysis for the free energy of binding calculations. Results: STK630921 is relatively able to stabilize IL-17A. Important interaction residues identified during the MD simulations were: Thr35(A), Pro37(A), Tyr62(A), Pro63(A)(B), Ile66(A)(B), Trp67(A), Ile96(A)(B), Val98(A)(B) and Val117(A)(B). Conclusion: STK630921 disrupts the interaction of IL-17A to its receptor by binding and stabilizing IL17A.

Open-access reader

About this research paper

What this paper is about

Objective: This research aimed to investigate the stability of the STK630921-Interleukin 17A (IL-17A) complex and to predict important residues that interact during molecular dynamics simulations. Methods: Molecular docking simulations were performed, followed by molecular dynamics (MD) simulations and the free energy of binding calculations using YASARA-Structure. The identification of interacting residues was done using PyPLIF HIPPOS. Molecular docking simulations were performed on the IL-17A binding pocket with the compound 4-[({N-[(4-Oxo-3,4-dihydro-1-phthalazinyl) acetyl] alanyl} amino) methyl] cyclohexane carboxylic acid or known as STK630921. The best-docked pose was selected for the 50 ns MD simulations production run. The MD simulations snapshots were then analyzed to see the stability of IL-17A and for the identification of interacting residues, followed by Molecular Mechanics/Poisson–Boltzmann and surface area (MM/PBSA) analysis for the free energy of binding calculations. Results: STK630921 is relatively able to stabilize IL-17A. Important interaction residues identified during the MD simulations were: Thr35(A), Pro37(A), Tyr62(A), Pro63(A)(B), Ile66(A)(B), Trp67(A), Ile96(A)(B), Val98(A)(B) and Val117(A)(B). Conclusion: STK630921 disrupts the interaction of IL-17A to its receptor by binding and stabilizing IL17A.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: This research aimed to investigate the stability of the STK630921-Interleukin 17A (IL-17A) complex and to predict important residues that interact during molecular dynamics simulations. Methods: Molecular docking simulations were performed, followed by molecular dynamics (MD) simulations and the free energy of binding calculations using YASARA-Structure. The identification of interacting residues was done using PyPLIF HIPPOS. Molecular docking simulations were performed on the IL-17A binding pocket with the compound 4-[({N-[(4-Oxo-3,4-dihydro-1-phthalazinyl) acetyl] alanyl} amino) methyl] cyclohexane carboxylic acid or known as STK630921. The best-docked pose was selected for the 50 ns MD simulations production run. The MD simulations snapshots were then analyzed to see the stability of IL-17A and for the identification of interacting residues, followed by Molecular Mechanics/Poisson–Boltzmann and surface area (MM/PBSA) analysis for the free energy of binding calculations. Results: STK630921 is relatively able to stabilize IL-17A. Important interaction residues identified during the MD simulations were: Thr35(A), Pro37(A), Tyr62(A), Pro63(A)(B), Ile66(A)(B), Trp67(A), Ile96(A)(B), Val98(A)(B) and Val117(A)(B). Conclusion: STK630921 disrupts the interaction of IL-17A to its receptor by binding and stabilizing IL17A.

Key concepts: Molecular dynamics, Molecular mechanics, Chemistry, Docking (animal), Computational chemistry, Binding energy, Amino acid residue, Interaction energy

Related papers

Back to paper searchBrowse research topicsOriginal source
MOLECULAR DYNAMICS SIMULATIONS OF THE STK630921 INTERACTIONS TO INTERLEUKIN-17A — Research Paper | ScholarLens